Arteris (NASDAQ:AIP) Receives Buy Rating from Rosenblatt Securities

Rosenblatt Securities restated their buy rating on shares of Arteris (NASDAQ:AIP) in a report released on Friday morning,Benzinga reports. They currently have a $20.00 price objective on the stock.

AIP has been the subject of several other reports. TD Cowen reiterated a “buy” rating on shares of Arteris in a report on Wednesday, November 5th. Jefferies Financial Group raised Arteris to a “hold” rating in a research note on Tuesday, October 28th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a research note on Wednesday, January 21st. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $20.17.

Arteris Price Performance

Shares of Arteris stock opened at $14.62 on Friday. Arteris has a 1-year low of $5.46 and a 1-year high of $19.85. The business’s fifty day moving average price is $16.23 and its two-hundred day moving average price is $13.27. The company has a market capitalization of $638.60 million, a P/E ratio of -17.83 and a beta of 1.47.

Arteris (NASDAQ:AIP) last released its quarterly earnings results on Thursday, February 12th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.03. The business had revenue of $20.14 million during the quarter, compared to the consensus estimate of $18.55 million. On average, research analysts expect that Arteris will post -0.73 earnings per share for the current fiscal year.

Insider Activity

In other news, major shareholder Bayview Legacy, Llc sold 70,000 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $17.71, for a total transaction of $1,239,700.00. Following the sale, the insider owned 9,469,071 shares in the company, valued at $167,697,247.41. The trade was a 0.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO K Charles Janac sold 70,000 shares of the company’s stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $17.71, for a total transaction of $1,239,700.00. Following the completion of the sale, the chief executive officer owned 9,469,071 shares of the company’s stock, valued at approximately $167,697,247.41. This trade represents a 0.73% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 689,072 shares of company stock valued at $11,525,611. Corporate insiders own 29.10% of the company’s stock.

Institutional Trading of Arteris

Hedge funds and other institutional investors have recently modified their holdings of the business. Intech Investment Management LLC grew its holdings in shares of Arteris by 9.3% during the fourth quarter. Intech Investment Management LLC now owns 13,540 shares of the company’s stock valued at $210,000 after buying an additional 1,148 shares in the last quarter. Deutsche Bank AG grew its stake in Arteris by 7.7% during the 4th quarter. Deutsche Bank AG now owns 21,159 shares of the company’s stock valued at $328,000 after acquiring an additional 1,504 shares in the last quarter. BNP Paribas Financial Markets increased its holdings in shares of Arteris by 75.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after purchasing an additional 2,595 shares during the period. Public Employees Retirement System of Ohio lifted its position in shares of Arteris by 12.3% in the third quarter. Public Employees Retirement System of Ohio now owns 23,913 shares of the company’s stock worth $242,000 after purchasing an additional 2,613 shares in the last quarter. Finally, Strs Ohio boosted its holdings in shares of Arteris by 16.5% during the third quarter. Strs Ohio now owns 20,500 shares of the company’s stock worth $207,000 after purchasing an additional 2,900 shares during the period. Institutional investors and hedge funds own 64.36% of the company’s stock.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Q4 2025 results beat expectations: EPS of ($0.05) topped estimates and revenue of $20.14M beat consensus; management issued above‑consensus revenue guidance for Q1 and FY‑2026 — a clear fundamental positive supporting upside. Read More.
• Positive Sentiment: Commercial traction: Arteris reported its network‑on‑chip technology has shipped in over 4 billion devices, a credibility milestone that supports longer‑term revenue expansion in AI and edge markets. Read More.
• Positive Sentiment: Strategic moves: Management outlined a >$100M contract‑value target for 2026 and strengthened chip security capability via the Cycuity acquisition — both bolster the company’s addressable market and product offering. Read More.
• Positive Sentiment: Analyst/institutional support: Rosenblatt reaffirmed a Buy and $20 PT; several funds increased or initiated positions recently, which provides bench‑marked upside versus the current price.
• Neutral Sentiment: Earnings materials and call transcripts are available for deeper read‑throughs — these will be sources of further guidance detail and management color that could move shares. Read More.
• Neutral Sentiment: Short‑interest data in feeds is inconsistent (entries showing 0/NaN vs earlier reported short positions), so short‑squeeze risk is unclear until exchanges reconcile figures.
• Negative Sentiment: Large insider/major‑holder selling: CEO K. Charles Janac (and major holder Bayview Legacy, LLC) sold sizeable blocks in recent days (47,244 shares on Feb 9 plus additional sales), creating added supply and pressuring sentiment. Read More.
• Negative Sentiment: Mixed research view: some shops (Weiss) remain negative; consensus is a Hold with a $17.50 average target — divergent analyst views can increase short‑term volatility.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.